Cryptophycin
Cryptophycins are a family of macrolide molecules that are potent cytotoxins and have been studied for potential antiproliferative properties useful in developing chemotherapy. They are members of the depsipeptide family. See more Cryptophycins were originally discovered in 1990 in cyanobacteria of the genus Nostoc. Cryptophycins were patented as antifungal agents with an unknown mechanism of action and subsequently identified as See more Cryptophycins are potent microtubule inhibitors, with a mechanism of action similar to that of vinca alkaloids. Treatment of cells … See more Cryptophycins were first isolated from cyanobacteria but have subsequently been produced by chemical synthesis. Chemoenzymatic … See more Members of the cryptophycin family have been studied as anti-tumor agents. Cryptophycin-52, a synthetic analog of natural product cryptophycins also known as LY355703, reached phase II clinical trials but was withdrawn due to side effects. See more WebCryptophycin 52 has demonstrated a broad range of antitumor activity against both murine and human tumors. In the human MX-1 breast carcinoma xenograft cryptophycin 55 produced greater-than- additive tumor response in combination with 5-fluorouracil. In human non-small cell lung carcinoma and human small cell carcinoma xenografts ...
Cryptophycin
Did you know?
WebJun 7, 2024 · The cryptophycin conjugates display high in vitro potency with IC 50 values between 22.3–287.5 n M, showing slightly reduced activity compared to cryptophycin-55 glycinate. Moreover, conjugates bearing cleavable linker ( 10, 11) are more cytotoxic than the corresponding uncleavable conjugates ( 13, 14 ). WebCryptophycin is a new anticancer drug discovered from micro-algae by researchers of the University of Hawaii and Wayne State University. Some of the cryptophycin analogs are …
WebThe cryptophycins are a unique family of 16-membered macrolide antimitotic agents isolated from the cyanobacteria Nostoc sp. Their molecular target is tubulin protein … WebCryptophycin 1 was kindly supplied by R. E. Schwartz, Merck, Sharp & Dohme Research Laboratories. PY - 1998/8/4 Y1 - 1998/8/4 N2 - The chloro-, bromo-, and iodo-derivatives 2-4 of the antimitotic drug cryptophycin 1 were synthesized by opening the epoxide ring.
Web吡啶-2-胺衍生物及其药物组合物和用途专利检索，吡啶-2-胺衍生物及其药物组合物和用途属于·对白血病有特异性的专利检索，找专利汇即可免费查询专利，·对白血病有特异性的专利汇是一家知识产权数据服务商，提供专利分析，专利查询，专利检索等数据服务功能。 WebKR102512597B1 KR1020247033500A KR20247033500A KR102512597B1 KR 102512597 B1 KR102512597 B1 KR 102512597B1 KR 1020247033500 A KR1020247033500 A KR 1020247033500A KR 20247033500 A KR20247033500 A KR 20247033500A KR 102512597 B1 KR102512597 B1 KR 102512597B1 Authority KR South Korea Prior art keywords cmet …
WebJul 15, 2016 · Abstract. Cryptophycins are a class of macrocyclic depsipeptides produced as secondary metabolites by cyanobacteria of the genus Nostoc and were found to bind to microtubules at the vinca site. The natural product C-1 isolated in 1990 and the synthetic derivative C-52 displayed potent in vitro and in vivo antitumor activity in preclinical …
WebJul 1, 2000 · Cryptophycins are active in breast and ovarian tumour cells that overexpress P glycoprotein and have shown promise in combination therapy with 5-fluorouracil, doxorubicin, paclit-axel and... foros gtmediaWebCryptophycin-309 (C-309) is a glycinate ester of the chlorohydrin Cryptophycin-296. The glycinate derivative provided both chemical stability and improved aqueous solubility. After the examination of 81 different Cryptophycin analogs in tumor bearing animals, C-309 has emerged as superior to all others. ... digimon story cyber sleuth ryota\\u0027s youthWebFIELD OF THE INVENTION. The present invention relates to the conjugation of a cytotoxic agent to a cell-binding molecule with branch linkers for having better pharmacokinetics in digimon story cyber sleuth quests